Can BDNF and IL-2 be indicators for the diagnosis in schizophrenic patients with depressive symptoms?

EKER S. S., Yavasci E. O., CANGÜR Ş., KIRLI S., Sarandol E.

ACTA NEUROPSYCHIATRICA, cilt.26, sa.5, ss.291-297, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 5
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1017/neu.2014.13
  • Dergi Adı: ACTA NEUROPSYCHIATRICA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.291-297
  • Anahtar Kelimeler: comorbidity, depression, psychoneuroimmunology, schizophrenia, NEUROTROPHIC FACTOR LEVELS, INFLAMMATORY RESPONSE SYSTEM, FACTOR SERUM CONCENTRATIONS, MAJOR DEPRESSION, INTERLEUKIN-2 PRODUCTION, ATYPICAL ANTIPSYCHOTICS, SOLUBLE INTERLEUKIN-2, BIPOLAR DISORDER, CSF LEVELS, BRAIN
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

Objective: The aim of the current study is to determine whether serum levels of brain-derived neurotrophic factor (BDNF) and interleukin-2 (IL-2) can be biological indicators for the diagnosis of schizophrenia in patients with depressive symptoms.